Psilocybin-Research.comSearchable psilocybin and psilocin bibliometrics.
Published

Refractory CRPS pain treated with psilocybin: A case report

Psilocybin shows promise as a treatment for CRPS, offering significant pain relief and functional improvement in a patient with refractory symptoms. This case highlights the need for further research into psilocybin's efficacy and optimal dosing for chronic pain management.

Open source BibTeX RIS

Bibliographic context

Journal
Clinical Case Reports
Date
2024-08-31
Source
OpenAlex
DOI
10.1002/ccr3.9421
PubMed
39281029

Authors

David S. JevotovskyHarman ChopraCourt WingCarlton J. SpotswoodJoel Castellanos
Watch author

Topics and keywords

psilocybin Chronic PainPharmacologyMechanism of ActionCase Report Case Report PsilocybinMedicineRefractory (planetary science)AnesthesiaHallucinogenPharmacologyPhysicsAstrobiologyPain Management and Placebo EffectPsychedelics and Drug StudiesPain Mechanisms and Treatments

Citation graph

0 referenced DOIs found in stored source metadata. 1 indexed paper cite this DOI.

Open citation network

Indexed papers citing this DOI

Refractory CRPS pain treated with psilocybin: A case report2024-08-31

Related papers

‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injuryInternal Medicine Journal · 2025-12-31Preadministration of Lorazepam Negates the Long-Term Antidepressant-Like Effects of Psilocybin in Male Wistar Kyoto RatsPsychedelic Medicine · 2025-12-15Advancing treatment paradigms: the role of psilocybin in managing major depressive disorderAnnals of Medicine and Surgery · 2025-11-23Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in ratsCell Reports Medicine · 2026-05-31Amid magic and menace: psychiatrists’ attitudes to psilocybin therapyIrish Journal of Psychological Medicine · 2024-11-06Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trialEClinicalMedicine · 2024-09-22Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment DevelopmentPsychedelic Medicine · 2023-09-05Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidenceAnnals of Medicine and Surgery · 2026-06-17